‘Groundbreaking' drug could slow down progression of type 1 diabetes
With type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body.
If blood sugar is too high or low, it can cause serious health problems and even death.
People with type 1 therefore need daily insulin.
Dentist and mother-of-two, Hannah Robinson, from Devon, is the first adult in the UK to try the drug in the hope it can delay the condition.
She is having treatment at the Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1.
A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS.
The 36-year-old said: 'For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin.
'This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition.
'This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this.'
The new drug teplizumab must be given at the earliest stage of the disease to be effective.
Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: 'This new treatment represents a really exciting shift in how we manage type 1 diabetes.
'For the first time ever, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin.
'Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment.
'My hope is that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all.'
Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes.
The hope is more people could be offered the drug to delay type 1.
Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: 'For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free.
'Right now, it's only available in research settings – and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit.
'That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale.
'Diabetes UK is proud to be at the forefront of these efforts – funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment for tackling the autoimmune attack at the root of type 1 diabetes.'
Professor Richard Oram, consultant physician at the Royal Devon and professor at the University of Exeter, said: 'Excitingly, teplizumab is the first drug with the potential to delay type 1 diabetes, but needs to be given before clinical diagnosis due to high blood glucose.
'It is really important to find new and improved approaches for identifying individuals at elevated risk.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
NHS cuts could lead to another Baby P or Victoria Climbie as safeguarding staff face axe, doctors warn
NHS cuts to key safety roles could trigger more abuse and child deaths, such as those of Baby P and Victoria Climbié, doctors and experts have warned. Medical staff responsible for safeguarding in their area are legally required to flag concerns about vulnerable patients, but their roles are at risk of being axed as local NHS bodies scramble to make government-imposed cost savings, doctors have told The Independent. Almost two dozen healthcare professionals, medical royal colleges, alongside children's charity the NSPCC, have written to Health Secretary Wes Streeting urging him to protect the roles. The letter to Mr Steeting, shared with The Independent, said: 'The NHS has a crucial role to play in protecting children. 'Given the scale and pace of reform, we ask you to urgently send a clear message to the public and all those who work to protect babies. This should guarantee that keeping children safe will remain a priority for the NHS and that ICBs will be fully resourced to carry out their child safeguarding duties.' The NSPCC warned that any cuts to safeguarding could result in a reduction in the tens of thousands of vital alerts already made by healthcare professionals every year - which has decreased since the pandemic, from 96,300 in 2020 to 91,370 in 2024. Dr Peter Green, chair of the national network of designated health professionals and doctors for child safeguarding, told The Independent there was a risk that cases such as Baby P, Victoria Climbié will occur more frequently as a result of any cuts. Dr Green said: 'There is a clear risk of those cases significantly increasing. The risk of those cases is obviously going to increase by not having the [NHS'] oversight and learning when things go wrong.' Baby P, Peter Connelly, died in August 2007 after suffering dozens of injuries at the hands of his mother, her boyfriend and his brother. A review of the high-profile case revealed a series of failings before his death by authorities, such as healthcare professionals and Haringey Council. Eight-year-old Victoria Climbie was murdered in 2000, by her aunt and her boyfriend, and an inquiry into her death led to sweeping changes to child protection laws. It is not known how many NHS safeguarding roles are at risk, but all local NHS bodies must make 50 per cent cuts to staffing as a result of the government's plans to abolish NHS England. Safeguarding was listed in official guidance as one area that could be targeted. 'Medical neglect' Urging Mr Streeting to protect the roles, the NSPCC also pointed to cases where children have died following horrific abuse or neglect, such as three-year-old Abiyah Yasharahyalah, Star Hobson, aged 1, and Arthur Labinjo-Hughes, aged 6. Abiyah died in 2020, having been starved by his parents and buried in their garden - a case which showed clear signs of 'medical neglect' was overlooked by authorities. The review into his care found agencies that came into contact with his family showed a "general lack of knowledge or assessment of the parents' belief systems", saw him kept on an extreme vegan diet, leading to an "insufficient understanding about the impact on his care". It concluded, his parents' culture and beliefs had a detrimental impact on his health, welfare and safety. He died from a respiratory illness, worsened by severe malnourishment, rickets, anaemia and stunted growth. According to the review, his parents failed to provide appropriate healthcare, ignored medical recommendations and cut off contact with health professionals who could support the child's condition. It also found opportunities for preventative care advice were missed as Abiyah was not brought to his health visiting assessments at one year old and two years old. A national review following Star's death in 2020 highlighted various gaps in the capacity of health services. One example given was significant increases in the workload for health visitors in the area that meant a pre-birth family health needs assessment was not conducted. And in Arthur's case, a limited capacity in children's mental health services before his death in 2020 may have impacted responses to his emotional and mental health needs. The NSPCC told The Independent that during the pandemic, health visitors who are key in spotting abuse were instead to work on Covid wards, and the 50 per cent still working as health visitors had their caseloads increased. In the same year, incidents of death or serious harm to children under one soared by almost a third in England. A Department of Health and Social Care spokesperson said: 'We are working closely with NHS England to maintain the safeguarding of vulnerable children and ensure their wellbeing remains at the heart of healthcare delivery. 'By reforming the NHS organisations, we are removing duplication and driving up efficiency, so they can provide better services for patients. 'We expect NHS organisations to work together and with other agencies in the interests of children and young people.'
BBC News
2 hours ago
- BBC News
Donations of rare blood type 'urgently needed' in South East
The NHS has pleaded for donations of a rare blood type, saying supplies are at risk of "running low". Some 2,500 eligible B negative donors in the south-east of England have been asked by the health service to boost stocks, which are currently "under pressure". More people with this type of blood have also been urged by the NHS to come forward as donors. NHS director of blood supply Gerry Gogarty said: "B negative donors are immensely important to our lifesaving work... it can be a challenge to always collect enough." Supplies were at one of the lowest points in recent years due to a shrinking donor base - following a loss of 1,000 donors since 2023 - and recent high demand, the NHS two per cent of the population has B negative blood, making it one of the rarest types, according to the NHS. Patients with the B negative blood type can only receive B negative or O negative blood, meaning that low stocks can also strain emergency supplies of this other blood across England need more than 5,000 blood donations every day, the NHS supplies are needed for a wide variety of reasons, including traumatic injuries or accidents, cancer treatments, sickle cell and childbirth, it continued. Mr Gogarty urged potential donors to book an appointment, use the GiveBlood app or call 0300 123 23 23.
The National
3 hours ago
- The National
Scottish hospital car park savings revealed for patients
The SNP said the savings meant keeping money 'in the pockets of NHS staff as well as patients and families at some of the most difficult times in their lives'. The figure was revealed in an answer to a written question tabled in Holyrood by Emma Harper on what savings had been made since the policy was scrapped during the SNP's first term in power. READ MORE: Pro-Palestine protesters drive van through fence of arms firm factory in Edinburgh Health Secretary Neil Gray said: 'The estimated saving for patients, visitors and staff who used NHS car parks that previously charged for car parking is over £90m.' Most Scottish hospitals have not charged for parking since 2008 however the Scottish Government was forced to buy out the private finance initiative (PFI) car parks at the Glasgow Royal Infirmary and Ninewells Hospital in Dundee in 2021 for £26.3m and £9m, respectively. (Image: Web) At that time, it was reported that talks with the PFI operator of the car park at the Royal Infirmary of Edinburgh were 'progressing' and NHS Lothian says that charges are currently suspended. While car parking fees can be a cash cow for the NHS, with trusts in England ploughing the money back into the health service, the SNP have long complained that visitors and staff were being charged to fund private companies leasing out car parks. READ MORE: UK set up secret Afghan migration scheme after massive data leak and media gagged SNP MSP Clare Haughey said: 'This is exactly the kind of action people expect from a government that puts public services first. 'By scrapping these unfair and unnecessary car parking charges, the SNP have saved people across Scotland more than £90m, money that stays in the pockets of NHS staff as well as patients and families at some of the most difficult times in their lives. 'While Westminster governments have allowed these charges to continue in parts of England, the SNP have delivered meaningful change that puts fairness and wellbeing first.'
